Correction to: Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS study

• 期刊论文

• 出版模式：

  开放获取

• 发表日期：

  2024年9月23日

• Weijun Fu,
• Soo-Mee Bang,
• Honghui Huang,
• Kihyun Kim,
• Wei Li,
• Gang An,
• Je-Jung Lee,
• Zhen Cai,
• Jie Jin,
• Yafei Wang,
• Chor Sang Chim,
• Robin Carson,
• Rui Liu,
• Man Zhao,
• Xi Chen,
• Canchan Cui,
• Jian Hou,
• Jianxiang Wang